Immunic, Inc. (IMUX)

Immunic Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	35.13	35.67	46.67	106.75	86.86	127.45
Short-Term Investments	-	-	-	9.63	-	-
Cash & Short-Term Investments	35.13	35.67	46.67	116.37	86.86	127.45
Cash Growth	-40.53%	-23.58%	-59.89%	33.97%	-31.85%	333.97%
Other Receivables	0.18	0.68	2.48	2.66	2.15	1.64
Receivables	0.18	0.68	2.48	2.66	2.15	1.64
Prepaid Expenses	3.15	1.87	2.31	5.61	15.98	4.65
Other Current Assets	0.82	1.11	1.07	1.23	-	-
Total Current Assets	39.27	39.33	52.53	125.86	104.99	133.75
Property, Plant & Equipment	1.43	1.54	1.77	1.85	1.1	1.1
Goodwill	-	-	-	-	32.97	32.97
Other Long-Term Assets	-	-	-	0.04	0.04	0.04
Total Assets	40.7	40.87	54.3	127.75	139.1	167.86
Accounts Payable	7.92	7.85	5.1	4.28	3.75	3.7
Accrued Expenses	19.45	12.91	18.66	7.99	7.07	4.32
Current Portion of Leases	0.67	0.74	0.7	0.57	0.41	0.3
Other Current Liabilities	2.04	0.68	0.27	0.24	0.18	0.08
Total Current Liabilities	30.08	22.18	24.73	13.08	11.4	8.4
Long-Term Leases	0.13	0.26	0.64	0.99	0.58	0.68
Total Liabilities	30.21	22.44	25.37	14.07	11.99	9.08
Common Stock	0.01	0.01	0	0	0	0
Additional Paid-In Capital	597.18	525.61	436.06	427.93	324.24	266.82
Retained Earnings	-589.27	-511.4	-410.89	-317.28	-196.87	-103.93
Comprehensive Income & Other	2.58	4.21	3.76	3.04	-0.25	-4.11
Total Common Equity	10.5	18.43	28.93	113.68	127.12	158.79
Shareholders' Equity	10.5	18.43	28.93	113.68	127.12	158.79
Total Liabilities & Equity	40.7	40.87	54.3	127.75	139.1	167.86
Total Debt	0.79	1	1.33	1.56	0.99	0.98
Net Cash (Debt)	34.34	34.66	45.34	114.81	85.87	126.48
Net Cash Growth	-40.97%	-23.55%	-60.51%	33.70%	-32.10%	338.41%
Net Cash Per Share	0.26	0.35	1.02	3.61	3.63	8.07
Filing Date Shares Outstanding	120.28	90.15	89.93	44.4	27.91	21.17
Total Common Shares Outstanding	98.65	90.15	45.18	39.31	26.34	21.17
Working Capital	9.19	17.16	27.81	112.79	93.59	125.35
Book Value Per Share	0.11	0.20	0.64	2.89	4.83	7.50
Tangible Book Value	10.5	18.43	28.93	113.68	94.15	125.82
Tangible Book Value Per Share	0.11	0.20	0.64	2.89	3.57	5.94

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q